Abstract:With high prevalence of type 2 diabetes worldwide, diabetic complications have been a major health problem, which reduce life quality and induce premature death in adults. The prevalence of type 2 diabetes is closely related to obesity and aging, two major risk factors for metabolic disorders. The diabetic complications, including retinopathy, nephropathy, neuropathy, skin ulcer, and atherosclerosis, are risk factors for mortality of patients. Retinopathy, nephropathy, and skin ulcer are representatives of microvascular complications, which often happen in insulin-deficient diabetic conditions, such as type 1 diabetic patients and some late-stage type 2 diabetic patients when β-cells completely lose function. Atherosclerosis that is often found in type 2 diabetes is a complication of macrovascular disease that increases the risk for myocardial infarction and strokes. However, atherosclerosis is receiving more and more appreciation in type 1 diabetes. Endothelial cells that line the inner vessel have been extensively studied in the mechanism of the diabetic complications. Impaired endothelial cell function is a common cellular mechanism for most of the diabetic complications (retinopathy, nephropathy, skin ulcer, and atherosclerosis). The cells are exposed to the high level of glucose in diabetic condition and subjected to glucose-induced stresses. The stress may cause overproliferation and deficiency in proliferation of endothelial cells, which contribute to dysfunction of microcirculation. Prevention and treatment of the complications are dependent on protection of the endothelial cell functions in most cases. In this issue, the mechanism of endothelial cell dysfunction was investigated in several studies to understand the molecular events by which the endothelial cells are impaired by hyperglycemia. This topic is enhanced with another group of studies about intervention of the endothelial complications with antioxidant compounds and new drug candidates. These studies will help readers to understand the current status and gain new insights into the diabetic complications. Weiping Jia Aimin Xu Alex Chen Jiarui Wu Jianping Ye

Roles of Endovascular Calyx Related Enzymes in Endothelial Dysfunction and Diabetic Vascular Complications

Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications

Endothelial Dysfunction and Platelet Hyperactivation in Diabetic Complications Induced by Glycemic Variability

Diabetic Endothelium Dysfunction, Cardiovascular Complications, and Therapeutics

The Role of Autophagy of Endothelial Cells in Diabetic Vascular Diseases

Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy

Chronic Vascular Complications in Diabetes

Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes

New Insights of Mu-Calpain in the Pathogenesis of Diabetic Vascular Injury

The role of glucagon-like peptide-1/GLP-1R and autophagy in diabetic cardiovascular disease

Endothelial extracellular vesicles: their possible function and clinical significance in diabetic vascular complications

The Loss of Endothelial Glycocalyx in Diabetic Retinopathy.

Vascular Endothelial Specific Growth Factors and Diabetic Nephropathy

Application of Endothelin Receptor Antagonists in Diabetic Complication

Endothelial Glycocalyx Degradation in Critical Illness and Injury

Endothelial-to-mesenchymal transition: An underappreciated mediator of diabetic complications

The glycocalyx, a novel key in understanding of mechanism of diabetic nephropathy: a commentary

Enos:A Key Factor Behind the Dysfunction of Endothelial Progenitor Cells in Diabetes Mellitus

The Underlying Mechanisms of Dysfunction of Endothelial Progenitor Cells Caused by Diabetes

Organelle dynamics of endothelial mitochondria in diabetic angiopathy

Advanced Glycation End Products and Diabetic Vascular Complications